1-17 of 17
Daniel R. Rhodes
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract CT059: StrataPATHTM: a multicohort, non-randomized, open-label phase 2 trial to explore efficacy and safety of FDA-approved cancer therapies in novel biomarker-guided patient population

Kat Kwiatkowski, Laura E. Lamb, Scott A. Tomlins, D. Brian Johnson, Daniel H. Hovelson, Nickolay Khazanov, Benjamin J. Bulen, Travis Reeder, Daniel R. Rhodes
Journal: Cancer Research
Cancer Res (2023) 83 (8_Supplement): CT059.
https://doi.org/10.1158/1538-7445.AM2023-CT059
Published: 14 April 2023
View article titled, Abstract CT059: StrataPATH<sup>TM</sup>: a multicohort, non-randomized, open-label phase 2 trial to explore efficacy and safety of FDA-approved cancer therapies in novel biomarker-guided patient population
Journal Articles

Abstract 968: Evaluation of Her2 RNA expression as a potential predictive biomarker for anti-Her2 therapy

Laura E. Lamb, Nickolay A. Khazanov, Daniel H. Hovelson, Kat Kwiatkowski, D. Bryan Johnson, Daniel R. Rhodes, Scott A. Tomlins
Journal: Cancer Research
Cancer Res (2023) 83 (7_Supplement): 968.
https://doi.org/10.1158/1538-7445.AM2023-968
Published: 04 April 2023
View article titled, Abstract 968: Evaluation of Her2 RNA expression as a potential predictive biomarker for anti-Her2 therapy
Journal Articles

Abstract 2171: A multivariate biomarker predicts sacituzumab govitecan response in solid tumors

Nickolay A. Khazanov, Laura E. Lamb, Daniel H. Hovelson, Kat Kwiatkowski, D. Bryan Johnson, Daniel R. Rhodes, Scott A. Tomlins
Journal: Cancer Research
Cancer Res (2023) 83 (7_Supplement): 2171.
https://doi.org/10.1158/1538-7445.AM2023-2171
Published: 04 April 2023
View article titled, Abstract 2171: A multivariate biomarker predicts sacituzumab govitecan response in solid tumors
Journal Articles

Abstract 4348: Validation of an integrative pan-solid tumor predictor of pembrolizumab monotherapy benefit

Benjamin J. Bulen, Nickolay A. Khazanov, Laura E. Lamb, Daniel H. Hovelson, Kat Kwiatkowski, D. Bryan Johnson, Daniel R. Rhodes, Scott A. Tomlins
Journal: Cancer Research
Cancer Res (2023) 83 (7_Supplement): 4348.
https://doi.org/10.1158/1538-7445.AM2023-4348
Published: 04 April 2023
View article titled, Abstract 4348: Validation of an integrative pan-solid tumor predictor of pembrolizumab monotherapy benefit
Journal Articles

The CARMA3–Bcl10–MALT1 Signalosome Drives NFκB Activation and Promotes Aggressiveness in Angiotensin II Receptor–Positive Breast Cancer

Prasanna Ekambaram, Jia-Ying (Lloyd) Lee, Nathaniel E. Hubel, Dong Hu, Saigopalakrishna Yerneni, Phil G. Campbell, Netanya Pollock, Linda R. Klei, Vincent J. Concel, Phillip C. Delekta, Arul M. Chinnaiyan, Scott A. Tomlins, Daniel R. Rhodes, Nolan Priedigkeit, Adrian V. Lee, Steffi Oesterreich, Linda M. McAllister-Lucas, Peter C. Lucas
Journal: Cancer Research
Cancer Res (2018) 78 (5): 1225–1240.
https://doi.org/10.1158/0008-5472.CAN-17-1089
Published: 28 February 2018
View article titled, The CARMA3–Bcl10–MALT1 Signalosome Drives NFκB Activation and Promotes Aggressiveness in Angiotensin II Receptor–Positive Breast Cancer
Open the PDF for The CARMA3–Bcl10–MALT1 Signalosome Drives NFκB Activation and Promotes Aggressiveness in Angiotensin II Receptor–Positive Breast Cancer in another window
Includes: Supplementary data
Journal Articles

Genomic Profiling of Penile Squamous Cell Carcinoma Reveals New Opportunities for Targeted Therapy

Andrew S. McDaniel, Daniel H. Hovelson, Andi K. Cani, Chia-Jen Liu, Yali Zhai, Yajia Zhang, Alon Z. Weizer, Rohit Mehra, Felix Y. Feng, Ajjai S. Alva, Todd M. Morgan, Jeffrey S. Montgomery, Javed Siddiqui, Seth Sadis, Santhoshi Bandla, Paul D. Williams, Kathleen R. Cho, Daniel R. Rhodes, Scott A. Tomlins
Journal: Cancer Research
Cancer Res (2015) 75 (24): 5219–5227.
https://doi.org/10.1158/0008-5472.CAN-15-1004
Published: 14 December 2015
View article titled, Genomic Profiling of Penile Squamous Cell Carcinoma Reveals New Opportunities for Targeted Therapy
Open the PDF for Genomic Profiling of Penile Squamous Cell Carcinoma Reveals New Opportunities for Targeted Therapy in another window
Includes: Supplementary data
Journal Articles

Abstract A1-43: Targeted amplicon-based next-generation sequencing of routine solid tumor specimens to detect clinically relevant somatic alterations

Daniel H. Hovelson, Andrew S. McDaniel, Bryan Johnson, Andi K. Cani, Kate Rhodes, Paul D. Williams, Chia-Jen Liu, Santhoshi Bandla, Catherine S. Grasso, Michael J. Quist, Seth Sadis, Daniel R. Rhodes, Scott A. Tomlins
Journal: Cancer Research
Cancer Res (2015) 75 (22_Supplement_1): A1-43.
https://doi.org/10.1158/1538-7445.TRANSCAGEN-A1-43
Published: 15 November 2015
View article titled, Abstract A1-43: Targeted amplicon-based next-generation sequencing of routine solid tumor specimens to detect clinically relevant somatic alterations
Journal Articles

Abstract 2897: Discovery and characterization of driver MAPK and PI3K pathway mutations in tumors and association with drug response in cell lines.

Mark Tomilo, Paul D. Williams, Emma T. Bowden, Supra R. Gajjala, Santhoshi Bandla, Sean F. Eddy, Seth E. Sadis, Peter J. Wyngaard, Nickolay A. Khazanov, Daniel R. Rhodes
Journal: Cancer Research
Cancer Res (2013) 73 (8_Supplement): 2897.
https://doi.org/10.1158/1538-7445.AM2013-2897
Published: 15 April 2013
View article titled, Abstract 2897: Discovery and characterization of driver MAPK and PI3K pathway mutations in tumors and association with drug response in cell lines.
Journal Articles

Abstract 3173: High-throughput, systematic analysis of paired-end next-generation sequencing data to characterize the gene fusion landscape in cancer.

Seth E. Sadis, Nickolay A. Khazanov, Armand R. Bankhead, Dinesh Cyanam, Paul D. Williams, Sean F. Eddy, Peter J. Wyngaard, Daniel R. Rhodes
Journal: Cancer Research
Cancer Res (2013) 73 (8_Supplement): 3173.
https://doi.org/10.1158/1538-7445.AM2013-3173
Published: 15 April 2013
View article titled, Abstract 3173: High-throughput, systematic analysis of paired-end next-generation sequencing data to characterize the gene fusion landscape in cancer.
Journal Articles

Abstract 3664: Breast cancer companion diagnostic platform based on objectively defined tumor co-expression patterns stratifies multiple clinical and therapeutic endpoints comparison to existing molecular subtyping definitions

Daniel R. Rhodes, Scott Tomlins, Dafydd G. Thomas, Paul Williams, Peter Wyngaard, Seth Sadis, Kahuku Oades, Lien Vo, Sukla Chattopadhyay, Yipeng Wang, Byung-In Lee, Joseph Monforte
Journal: Cancer Research
Cancer Res (2012) 72 (8_Supplement): 3664.
https://doi.org/10.1158/1538-7445.AM2012-3664
Published: 15 April 2012
View article titled, Abstract 3664: Breast cancer companion diagnostic platform based on objectively defined tumor co-expression patterns stratifies multiple clinical and therapeutic endpoints comparison to existing molecular subtyping definitions
Journal Articles

Abstract 2815: Urine TMPRSS2:ERG for prostate cancer risk stratification in men with elevated serum PSA

Scott A. Tomlins, Sheila Aubin, Javed Siddiqui, Robert Lonigro, Laurie Sefton-Miller, Siobhan Miick, Sarah Williamsen, Petrea Hodge, Jessica Meinke, Amy Blase, Yvonne Penabella, John Day, Daniel R. Rhodes, Kyoko Sakamoto, Jonathan Silberstein, Yves Fradet, James B. Amberson, Stephanie Meyers, Harry Rittenhouse, John T. Wei, Jack Groskopf, Arul M. Chinnaiyan
Journal: Cancer Research
Cancer Res (2011) 71 (8_Supplement): 2815.
https://doi.org/10.1158/1538-7445.AM2011-2815
Published: 15 April 2011
View article titled, Abstract 2815: Urine TMPRSS2:ERG for prostate cancer risk stratification in men with elevated serum PSA
Journal Articles

Abstract 3149: OncoPredictor: A systematic approach for predicting responsive cancer populations from large scale cell line screening

Mark Tomilo, Sean F. Eddy, Wendy Lockwood Banka, Seth E. Sadis, Paul D. Williams, Peter J. Wyngaard, Christine O'Day, Yulia Ovechkino, Usha Warrior, Daniel R. Rhodes
Journal: Cancer Research
Cancer Res (2011) 71 (8_Supplement): 3149.
https://doi.org/10.1158/1538-7445.AM2011-3149
Published: 15 April 2011
View article titled, Abstract 3149: OncoPredictor: A systematic approach for predicting responsive cancer populations from large scale cell line screening
Journal Articles

A Polycomb Repression Signature in Metastatic Prostate Cancer Predicts Cancer Outcome

Jindan Yu, Jianjun Yu, Daniel R. Rhodes, Scott A. Tomlins, Xuhong Cao, Guoan Chen, Rohit Mehra, Xiaoju Wang, Debashis Ghosh, Rajal B. Shah, Sooryanarayana Varambally, Kenneth J. Pienta, Arul M. Chinnaiyan
Journal: Cancer Research
Cancer Res (2007) 67 (22): 10657–10663.
https://doi.org/10.1158/0008-5472.CAN-07-2498
Published: 15 November 2007
View article titled, A Polycomb Repression Signature in Metastatic Prostate Cancer Predicts Cancer Outcome
Open the PDF for A Polycomb Repression Signature in Metastatic Prostate Cancer Predicts Cancer Outcome in another window
Includes: Supplementary data
Journal Articles

TMPRSS2:ETV4 Gene Fusions Define a Third Molecular Subtype of Prostate Cancer

Scott A. Tomlins, Rohit Mehra, Daniel R. Rhodes, Lisa R. Smith, Diane Roulston, Beth E. Helgeson, Xuhong Cao, John T. Wei, Mark A. Rubin, Rajal B. Shah, Arul M. Chinnaiyan
Journal: Cancer Research
Cancer Res (2006) 66 (7): 3396–3400.
https://doi.org/10.1158/0008-5472.CAN-06-0168
Published: 03 April 2006
View article titled, <em>TMPRSS2:ETV4</em> Gene Fusions Define a Third Molecular Subtype of Prostate Cancer
Open the PDF for <em>TMPRSS2:ETV4</em> Gene Fusions Define a Third Molecular Subtype of Prostate Cancer in another window
Journal Articles

Overexpression, Amplification, and Androgen Regulation of TPD52 in Prostate Cancer

Mark A. Rubin, Sooryanarayana Varambally, Rameen Beroukhim, Scott A. Tomlins, Daniel R. Rhodes, Pamela L. Paris, Matthias D. Hofer, Martina Storz-Schweizer, Rainer Kuefer, Jonathan A. Fletcher, Bae-Li Hsi, Jennifier A. Byrne, Kenneth J. Pienta, Colin Collins, William R. Sellers, Arul M. Chinnaiyan
Journal: Cancer Research
Cancer Res (2004) 64 (11): 3814–3822.
https://doi.org/10.1158/0008-5472.CAN-03-3881
Published: 01 June 2004
View article titled, Overexpression, Amplification, and Androgen Regulation of TPD52 in Prostate Cancer
Open the PDF for Overexpression, Amplification, and Androgen Regulation of TPD52 in Prostate Cancer in another window
Journal Articles

Prostate cancer elicits a humoral immune response to α-methylacyl-CoA racemase

Arun Sreekumar, Bharathi Laxman, Daniel R. Rhodes, Srilakshmi Bhagavathula, Donald Giacherio, Debashis Ghosh, Martin G. Sanda, Mark A. Rubin, Arul M. Chinnaiyan
Journal: Cancer Research
Cancer Res (2004) 64 (7_Supplement): 1033.
Published: 01 April 2004
View article titled, Prostate cancer elicits a humoral immune response to α-methylacyl-CoA racemase
Journal Articles

Meta-Analysis of Microarrays: Interstudy Validation of Gene Expression Profiles Reveals Pathway Dysregulation in Prostate Cancer

Daniel R. Rhodes, Terrence R. Barrette, Mark A. Rubin, Debashis Ghosh, Arul M. Chinnaiyan
Journal: Cancer Research
Cancer Res (2002) 62 (15): 4427–4433.
Published: 01 August 2002
View article titled, Meta-Analysis of Microarrays: <subtitle>Interstudy Validation of Gene Expression Profiles Reveals Pathway Dysregulation in Prostate Cancer</subtitle>
Open the PDF for Meta-Analysis of Microarrays: <subtitle>Interstudy Validation of Gene Expression Profiles Reveals Pathway Dysregulation in Prostate Cancer</subtitle> in another window